Colin Smith Mackay
Chief Executive Officer at Symbiosis Pharmaceutical Services Ltd.
Profile
Colin Smith Mackay has held positions as Chief Executive Officer at Symbiosis Pharmaceutical Services Ltd.
and Director at Symbiosis Holdings (Scotland) Ltd.
Colin Smith Mackay active positions
| Companies | Position | Start |
|---|---|---|
Symbiosis Pharmaceutical Services Ltd.
 Symbiosis Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay. | Chief Executive Officer | - |
Symbiosis Holdings (Scotland) Ltd.
 Symbiosis Holdings (Scotland) Ltd. Financial ConglomeratesFinance Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK. | Director/Board Member | 2020-03-03 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Symbiosis Pharmaceutical Services Ltd.
Symbiosis Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay. | Health Technology |
Symbiosis Holdings (Scotland) Ltd.
Symbiosis Holdings (Scotland) Ltd. Financial ConglomeratesFinance Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK. | Finance |
- Stock Market
- Insiders
- Colin Smith Mackay
